City Offers Third COVID-19 Vaccine Dose for Immunocompromised Individuals

Translate to Spanish or other 102 languages!

The City of El Paso is now providing a third dose of the COVID-19 vaccine to individuals who are moderately to severely immunocompromised. Image for illustration purposes

Mega Doctor News

- Advertisement -

EL PASO, Texas – The City of El Paso is now providing a third dose of the COVID-19 vaccine to individuals who are moderately to severely immunocompromised.

A third dose will only be administered 28 days after receiving the second dose of either the Pfizer or Moderna vaccine to those who are moderately or severely immunocompromised individuals:

·         Receiving active cancer treatment for tumors or cancers of the blood

- Advertisement -

·         Received an organ transplant and are taking medicine to suppress the immune system

·         Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system

·         Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome and Wiskott-Aldrich syndrome)

·         Advanced or untreated HIV infection

- Advertisement -

·         Active treatment with high-dose corticosteroids or other drugs that may suppress the immune response

Individuals are strongly encouraged to talk to their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them. 

COVID-19 third doses are available by appointment only at the following locations:

·         301 George Perry

Monday – Saturday: 8 a.m. to Noon and 1 to 5 p.m.

·         El Paso Convention Center, 1 Civic Center Plaza

Monday – Friday: Noon to 6 p.m.

Saturday: 8 a.m. to 3 p.m.

·         City of El Paso COVID-19 Clinics

Monday – Saturday: 8 a.m. to Noon and 1 to 5 p.m.

o    220 S. Stanton (corner of First and Stanton)

o    9341 Alameda

o    7380 Remcon

o    9566 Railroad

To make an appointment visit EPCovidVaccine.com and click on the registration form, or call (915) 212-6843.

THIRD DOSE, NOT A BOOSTER

Health officials note that this third dose is NOT a booster. The third dose follows 28 days after an initial vaccine series is administered to people who may not have a strong enough immune response after receiving the initial vaccine series. A booster dose is a supplemental dose given to individuals whose immune response has weakened over time and administered eight (8) months after an initial vaccine series is administered. 

The City of El Paso is preparing to administer the booster shots in late September once federal and state guidelines are provided. Health officials remind the public to continue wearing face covers, wash your hands frequently and watch your distancing, regardless of whether you have or have not yet received the vaccine. Additional information about COVID-19, can be found at www.EPStrong.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Starr County Healthcare Workforce Gets $100K Boost via New Internship Fund

Workforce Solutions (WFS) announced the launch of the $100,000 Healthcare Internship Fund, an innovative workforce development initiative designed to create structured, paid internship opportunities for 91 students pursuing high-demand healthcare careers across the region.

4th of July Fireworks Safety Guide for Parents

As families gear up for backyard barbecues, fireworks displays and other Fourth of July celebrations, safety should be part of the preparation.

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

Dr. Michael Seawell Discusses Renal Denervation for Difficult-to-Control High Blood Pressure

Dr. Michael Seawell, a board-certified interventional cardiologist at DHR Health, is helping expand access to renal denervation, a minimally invasive treatment designed for patients with difficult-to-control high blood pressure.
- Advertisement -